Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis

Journal of Hepatology
Theodoros A ZografosGeorge N Dalekos

Abstract

Leptin has a particular profibrogenic role in the liver. We investigated whether IFN-alpha influences leptin production in patients with chronic hepatitis B (CHB) and C (CHC). Leptin was determined in serial samples from 63 CHB and 42 CHC IFN-alpha treated patients. Furthermore, we evaluated whether leptin alterations were associated with patients' characteristics. Sera were investigated at serial time-points using an enzyme-linked-immunosorbent-assay. Controls consisted of 36 patients with autoimmune liver diseases and 44 healthy patients. Leptin levels before IFN-alpha administration were higher in CHB and CHC compared to healthy (P<0.004) and diseased controls (P=0.0001). In CHB patients, we observed a significant reduction of leptin during IFN-alpha treatment and lasting for up to 6 months after the end of treatment, followed by an increase reaching pretreatment levels at 1.5 years after stopping therapy. The pattern of leptin alterations was similar in CHC patients where leptin's decrease was more pronounced at 6 months after the end of treatment. Biochemical or virological response to treatment was not associated with leptin reduction in both groups. This study provides information on leptin kinetics during IFN-alpha trea...Continue Reading

References

Sep 1, 1981·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R G KnodellJ Wollman
Aug 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S MihmG Ramadori
Mar 7, 1998·Annals of Internal Medicine·G N DalekosE V Tsianos
Mar 26, 1998·Biochemical and Biophysical Research Communications·J J PotterF A Anania
Oct 31, 1998·Nature·J M Friedman, J L Halaas
Mar 29, 2000·Seikagaku. The Journal of Japanese Biochemical Society·T Murakami
Jul 25, 2000·Journal of Hepatology·R TestaT Barreca
Oct 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T PoynardJ Albrecht
Nov 30, 2000·The American Journal of Gastroenterology·E GianniniR Testa
Jan 11, 2001·The American Journal of Gastroenterology·A UygunK Dagalp
Jun 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hajime HondaNobuhiro Sato
Jul 20, 2002·Journal of Hepatology·Isabelle A LeclercqGraham R Robertson
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael W Fried
Apr 15, 2003·Clinics in Liver Disease·Leonard B Seeff, Jay H Hoofnagle
Jun 12, 2003·Journal of Neuroimmunology·Anna Paola BatocchiMassimiliano Mirabella
Jun 18, 2003·The American Journal of Gastroenterology·Manuel Romero-GómezAntonio Robles
Aug 2, 2003·Scandinavian Journal of Gastroenterology·A ComlekciY Batur
Mar 5, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alexander MontoTeresa L Wright
Mar 25, 2004·Trends in Immunology·Giuseppe Matarese, Antonio La Cava
Jul 6, 2004·Progress in Lipid Research·F PeelmanJ Tavernier
Nov 4, 2004·Alimentary Pharmacology & Therapeutics·R J Aspinall, P J Pockros
Aug 11, 2005·Pediatrics International : Official Journal of the Japan Pediatric Society·Mukadder Ayşe Selimoglu, Vildan Ertekin
Aug 12, 2005·European Journal of Gastroenterology & Hepatology·Ferenc SzalayPeter Laszlo Lakatos
Aug 30, 2005·Annals of the New York Academy of Sciences·Roman RiegerM Eric Gershwin

❮ Previous
Next ❯

Citations

Sep 30, 2008·Der Pathologe·H P Dienes, U Drebber
Jun 2, 2007·BMC Gastroenterology·Spilios ManolakopoulosStamatios Theocharis
Jan 8, 2013·Clinical and Experimental Medicine·Nikolaos K GatselisGeorge N Dalekos
Jan 22, 2013·Atherosclerosis·George NtaiosGeorge N Dalekos
Jan 15, 2008·The American Journal of Gastroenterology·Theodoros A ZografosGeorge N Dalekos
Oct 5, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Nobuyoshi FukushimaMichio Sata
Jul 9, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fabio Marra, Cristiana Bertolani
Apr 12, 2011·Expert Review of Gastroenterology & Hepatology·Samuele De Minicis, Gianluca Svegliati-Baroni
Sep 23, 2020·Journal of Pediatric Gastroenterology and Nutrition·Ana Paula Bidutte CortezMauro Batista de Morais
Nov 11, 2020·International Journal of Molecular Sciences·Ming-Ling ChangSien-Sing Yang
Mar 13, 2021·Life Sciences·Arunraj Namachivayam, Abilash Valsala Gopalakrishnan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Fabio Marra, Cristiana Bertolani
Liver International : Official Journal of the International Association for the Study of the Liver
Sarah P GeorgiadouGeorge N Dalekos
© 2021 Meta ULC. All rights reserved